Pay in 4 interest-free payments of $6.82 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Tirzepatide is the first dual GIP/GLP-1 receptor co-agonist to win FDA approval for type 2 diabetes
Am J Physiol 1993;265(4 Pt 1):L374L381
Wegovy is a once-weekly injection thats given in the arm, leg or abdomen
There are three primary areas where these injections should be given: the abdomen, upper arm, and thigh
Click here to start the 2-minute quiz Coupons and Discounts Tone: Friendly Best friend giving advice Hey bestie
These medications help by: Increasing insulin production when needed Slowing stomach emptying Reducing hunger signals Promoting feelings of fullness Because of these effects, GLP-1 drugs have become widely prescribed for both diabetes management and weight loss
US$ 21.69
US$ 25.21
US$ 21.14
US$ 21.76
US$ 21.09
US$ 24.55
